Back to Search
Start Over
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation.
- Source :
-
Blood cancer journal [Blood Cancer J] 2022 Apr 20; Vol. 12 (4), pp. 69. Date of Electronic Publication: 2022 Apr 20. - Publication Year :
- 2022
- Subjects :
- Epigenesis, Genetic
Genes, Modifier
Humans
Mutation
Protein Kinase Inhibitors
Recurrence
Leukemia, Myelogenous, Chronic, BCR-ABL Positive diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics
Leukemia, Myeloid genetics
Subjects
Details
- Language :
- English
- ISSN :
- 2044-5385
- Volume :
- 12
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Blood cancer journal
- Publication Type :
- Report
- Accession number :
- 35443743
- Full Text :
- https://doi.org/10.1038/s41408-022-00667-9